NCT07344727

Brief Summary

The purpose of this clinical trial is to determine how certain food items affect oxidative stress, inflammation, and performance recovery from exercise induced muscle damage in a resistance trained population. The main questions The investigators aim to answer are the following:

  • Do Haskaps speed the recovery of oxidative stress and inflammation markers after an intense lower body workout in resistance trained adults?
  • Do Haskaps speed the recovery of performance measures after an intense lower body workout in resistance trained adults?
  • The data collected in this investigation may also be used to ask additional questions not yet identified. For example, the investigators may use the stored samples to evaluate how the blood metabolites of participants differ before and after intense exercise. These additional questions are called secondary analyses. Please note that no genetic analysis will be conducted and racial and ethnic differences among participants will not be used in any secondary analyses. Researches will compare Haskap juice to a color, flavor and carbohydrate matched placebo to see if Haskaps speed recovery in inflammation, oxidative stress and performance.
  • Participants will be asked to drink either Haskap juice or placebo and follow a low polyphenolic diet
  • Participants will perform an intense resistance workout
  • Participants will have their blood drawn before and after the workout
  • Performance will be analyzed at 24, 48 and 72 hours after the workout

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 21, 2025

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

January 7, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

January 15, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2026

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2026

Completed
Last Updated

January 21, 2026

Status Verified

January 1, 2026

Enrollment Period

4 months

First QC Date

January 7, 2026

Last Update Submit

January 19, 2026

Conditions

Keywords

exercise performanceresistance exerciserecoveryoxidative stressinflammation

Outcome Measures

Primary Outcomes (8)

  • Force Production

    Maximal Voluntary Contraction (MVC) to assess force production of knee extensors at 60 degrees.

    72 hours

  • Barbell Velocity

    Barbell velocity will be measure to determine how squat velocity recovers over the course of the study.

    72 hours

  • Vertical Jump

    Force plates will be used to evaluate vertical jump height.

    72 hours

  • Inflammation (pg/mL)

    Serum interleukin (IL) IL-6, IL-10, IL-1ra, tumor necrosis factor alpha (TNF-alpha),

    11 days

  • Lipid peroxidation

    Plasma Malondialdehyde (MDA)

    11 days

  • Creatine Kinase

    Plasma

    11 days

  • C-Reactive Protein

    Plasma

    11 days

  • Protein Carbonyls

    Plasma

    11 days

Secondary Outcomes (3)

  • Soreness

    72 hours

  • Acute Diet

    9 days

  • Sleep Questionnaire

    11 days

Study Arms (2)

Placebo Control

PLACEBO COMPARATOR

The placebo supplement will have no polyphenol content and will be carbohydrate-matched to the experimental group. A twice daily dose (10-12 hours apart) will be consumed for 11 days.

Dietary Supplement: Placebo Comparator

Haskap

EXPERIMENTAL

The haskap supplement will consist of a haskap berry smoothie. A twice daily dose (10-12) hours apart will be consumed for 11 days.

Dietary Supplement: Haskap berry smoothie

Interventions

Haskap berry smoothieDIETARY_SUPPLEMENT

A smoothie blend of berries and water

Haskap
Placebo ComparatorDIETARY_SUPPLEMENT

A smoothie with no polyphenolic content and matched in carbohydrate composition to the experimental haskap smoothie

Placebo Control

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • + years of barbell squat experience
  • Currently squatting at least once a week

You may not qualify if:

  • BMI \<18 or \> 40 kg/m\^2
  • potential allergy to Haskap or placebo ingredients
  • anti-inflammatory, weight loss, anabolic steroids, testosterone, or other drugs that may interfere with the measures of the study or any other medications that may interfere with study measures
  • pregnant or lactating woman
  • diagnosis with type 1 or type 2 diabetes, hypo-/hyperthyroidism or any other condition that may interfere with study measures
  • smoke cigarettes
  • lower extremity injury within the last year
  • currently following a special diet including vegan, vegetarian, low carbohydrate, or ketogenic.
  • currently consuming any of the following products: tart cherry juice, pomegranate juice, or 1 or more cups of acai or other berries per day.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Montana State University

Bozeman, Montana, 59715, United States

RECRUITING

MeSH Terms

Conditions

Inflammation

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Mary P Miles

    Montana State University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Placebo and haskap interventions were designed to be comparable in taste, carbohydrate content, and appearance.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 7, 2026

First Posted

January 15, 2026

Study Start

October 21, 2025

Primary Completion

March 1, 2026

Study Completion

May 1, 2026

Last Updated

January 21, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations